These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. X-ray crystallographic structures as a source of ligand alignment in 3D-QSAR. Urniaż RD; Jóźwiak K J Chem Inf Model; 2013 Jun; 53(6):1406-14. PubMed ID: 23705769 [TBL] [Abstract][Full Text] [Related]
29. Preparation of protein crystals for X-ray structural study. Takeda S Methods Mol Med; 2006; 129():291-303. PubMed ID: 17085819 [TBL] [Abstract][Full Text] [Related]
30. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design. Moore J; Abdul-Manan N; Fejzo J; Jacobs M; Lepre C; Peng J; Xie X J Synchrotron Radiat; 2004 Jan; 11(Pt 1):97-100. PubMed ID: 14646145 [TBL] [Abstract][Full Text] [Related]
31. The advantages and limitations of protein crystal structures. Acharya KR; Lloyd MD Trends Pharmacol Sci; 2005 Jan; 26(1):10-4. PubMed ID: 15629199 [TBL] [Abstract][Full Text] [Related]
32. Industrial perspective on X-ray data collection and analysis. Skarzynski T; Thorpe J Acta Crystallogr D Biol Crystallogr; 2006 Jan; 62(Pt 1):102-7. PubMed ID: 16369099 [TBL] [Abstract][Full Text] [Related]
33. Life in the fast lane for protein crystallization and X-ray crystallography. Pusey ML; Liu ZJ; Tempel W; Praissman J; Lin D; Wang BC; Gavira JA; Ng JD Prog Biophys Mol Biol; 2005 Jul; 88(3):359-86. PubMed ID: 15652250 [TBL] [Abstract][Full Text] [Related]
34. Kinetic products in coordination networks: ab initio X-ray powder diffraction analysis. Martí-Rujas J; Kawano M Acc Chem Res; 2013 Feb; 46(2):493-505. PubMed ID: 23252592 [TBL] [Abstract][Full Text] [Related]
35. The computational prediction of pharmaceutical crystal structures and polymorphism. Price SL Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583 [TBL] [Abstract][Full Text] [Related]
36. Preparation and crystallization of RNA. Golden BL Methods Mol Biol; 2007; 363():239-57. PubMed ID: 17272845 [TBL] [Abstract][Full Text] [Related]
38. Synergy within structural biology of single crystal optical spectroscopy and X-ray crystallography. De la Mora-Rey T; Wilmot CM Curr Opin Struct Biol; 2007 Oct; 17(5):580-6. PubMed ID: 17959373 [TBL] [Abstract][Full Text] [Related]
39. A medicinal chemistry perspective on structure-based drug design and development. Maddaford SP Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460 [TBL] [Abstract][Full Text] [Related]
40. [Advances in the quantitative analytical methods of drug polymorphism]. Ma LW; Du W; Zhao CS Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]